Pediatrics

Ser/dex is a dexmethylphenidate-based prodrug for ADHD in patients 6 years and older.

For children who have either experienced a delay in pertussis vaccination or who haven’t received the recommended number of doses, what is their risk of pertussis? A new study provides answers.

At the virtual Scientific Sessions for the American Diabetes Association, Jennifer Sherr, MD, discussed the findings of a study of the Omnipod 5 automated insulin delivery system in very young children with type 1 diabetes.

There was a marked decline in child and adolescent routine vaccine administration during the COVID-19 pandemic between March and September 2020; these vaccination rates have continued to lag behind.

Viloxazine is a selective norepinephrine reuptake inhibitor and is the first new nonstimulant medication for treatment of ADHD in children in more than 10 years.

The FDA approved Cosentyx (secukinumab) to treat moderate-to-severe plaque psoriasis in children aged 6 years and older.

The company has publicized data from the TeenCOVE study of the vaccine along with plans to seek authorization in the coming weeks.

The Practice Advisory, developed by the American College of Obstetricians and Gynecologists (ACOG), offers an overview of the latest guidance for COVID-19 vaccination in pregnant and lactating patients.

The FDA has expanded the emergency use authorization for the COVID-19 vaccine to include individuals 12 to 15 years of age.

The approval marks the first novel non-stimulant treatment for ADHD.

Pfizer/BioNTech released data on their COVID-19 vaccine that indicates high efficacy in children aged 12 to 15 years.

A recent study examined how insulin levels and body mass index may have ties to mental health concerns.

Prefilled syringes have been the way that many children with juvenile idiopathic arthritis get their methotrexate. A pilot study examines if prefilled pens might be a better option.

Acetaminophen may be the antipyretic choice for many families, but a new study asks whether it could be a problem for children with asthma.

US health care workers have started receiving the COVID-19 vaccine, but we are still months away from approving the vaccine for use in children, according to Fauci.

In the wake of a resurgence of measles cases and deaths globally, experts are worried about the decline in vaccinations during the pandemic.

Often what parents reach for to relieve a child’s pain or fever, a new meta-analysis looks at the efficacy and safety of ibuprofen and acetaminophen.

MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Thinking Long-Term: COVID-19’s Clinical Consequences and Mental Health Effects."

The FDA approved the treatment through the prescription-to-OTC switch process.

The program is designed to prepare state-licensed pharmacists to meet requirements for administering vaccinations to pediatric patients.

A poster at the virtual 2020 ID Week looked at how vaccine type can impact diphtheria, tetanus, and acellular pertussis (DTaP) vaccination.

Controlling exposure to antibiotics is important for stewardship programs, and even more so in neonatal intensive care units.

The new guidance provides clarification on requirements for pharmacy interns and technicians to administer childhood and COVID-vaccines, as well as COVID-19 tests.

Results of a phase 3 trial showed clinical benefits with dupilumab (Dupixent; Sanofi and Regeneron) in children with uncontrolled moderate-to-severe asthma.

An investigation examines whether an intervention including both school and home components improves asthma outcomes.

Tofacitinib (Xeljanz; Pfizer) is the first and only Janus kinase inhibitor approved in the US for this indication.

A recent report looked at whether human papilloma virus (HPV) vaccination coverage will meet the Healthy People 2020 goal.

The American Academy of Pediatrics (AAP) has issued its recommendations for the 2020-2021 influenza season.

The MiniMed 770G system (Medtronic) is approved for use by individuals aged 2 to 6 with type 1 diabetes.

NACDS is urging states to provide clarity on pharmacist-provided childhood vaccinations, and enhance overall patient access to vaccines.